Universal Biospecimen Collection Protocol for Extra Material From Clinical Pulmonary Procedures

M.D. Anderson Cancer Center12,000 enrolled

Overview

The goal of this study is to develop a biospecimen collection protocol for unused biospecimens from pulmonary procedures in order to facilitate research across many different areas of pulmonary medicine and mitigate the pulmonary morbidity experienced by patients with cancer.

Primary objectives: To assemble a tissue/blood bank biorepository for laboratory translational research by collecting extra samples of bronchoalveolar lavage, pleural fluid, blood or other residual tissue obtained during normally scheduled clinical procedures for the evaluation of pulmonary toxicity To collect basic data on patient data and suspected pulmonary toxicity to cross-reference eligible biospecimens

Study Type

OBSERVATIONAL

Enrollment

12,000

Conditions

Pulmonary

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: All patients over the age of 18, who are seen in the Cardiopulmonary Center and are undergoing pulmonary procedures Exclusion Criteria: Pregnant women and prisoners

Locations (1)

The University of Texas M. D. Anderson Cancer Center

Houston, Texas, United States

RECRUITING

Outcomes

Primary Outcomes

Safety and Adverse Events (AEs)

Incidence of Adverse Events, Graded According to National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE) Version (v) 5.0

Time frame: Through study completion; an average of 1 year

Central Contacts

Ajay Sheshadri, MD

CONTACT

(713) 563-1987 asheshadri@mdanderson.org

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.